More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use ...

NSDUH only queried opioid misusers about opioid use disorder symptoms. After they changed the protocol and asked all ...

To date Mesa received $4.5 million in One Arizona settlement funds. The city will give $1 million to nonprofits working to ...

What is the argument that makes addiction more deserving of free treatment than heart disease or mental illness? Perhaps all ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

Around two-thirds of people relapse within 30 days after being discharged from residential treatment. An app could help them ...